206 related articles for article (PubMed ID: 20056600)
1. Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds.
Colombo G; Margosio B; Ragona L; Neves M; Bonifacio S; Annis DS; Stravalaci M; Tomaselli S; Giavazzi R; Rusnati M; Presta M; Zetta L; Mosher DF; Ribatti D; Gobbi M; Taraboletti G
J Biol Chem; 2010 Mar; 285(12):8733-42. PubMed ID: 20056600
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors.
Taraboletti G; Rusnati M; Ragona L; Colombo G
Oncotarget; 2010 Nov; 1(7):662-673. PubMed ID: 21317461
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.
Margosio B; Rusnati M; Bonezzi K; Cordes BL; Annis DS; Urbinati C; Giavazzi R; Presta M; Ribatti D; Mosher DF; Taraboletti G
Int J Biochem Cell Biol; 2008; 40(4):700-9. PubMed ID: 17996481
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2.
Margosio B; Marchetti D; Vergani V; Giavazzi R; Rusnati M; Presta M; Taraboletti G
Blood; 2003 Dec; 102(13):4399-406. PubMed ID: 12947001
[TBL] [Abstract][Full Text] [Related]
6. PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1.
Pinessi D; Foglieni C; Bugatti A; Moroni E; Resovi A; Ribatti D; Rusnati M; Giavazzi R; Colombo G; Taraboletti G
Thromb Res; 2016 Apr; 140 Suppl 1():S182. PubMed ID: 27161705
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
[TBL] [Abstract][Full Text] [Related]
8. Direct and allosteric inhibition of the FGF2/HSPGs/FGFR1 ternary complex formation by an antiangiogenic, thrombospondin-1-mimic small molecule.
Pagano K; Torella R; Foglieni C; Bugatti A; Tomaselli S; Zetta L; Presta M; Rusnati M; Taraboletti G; Colombo G; Ragona L
PLoS One; 2012; 7(5):e36990. PubMed ID: 22606323
[TBL] [Abstract][Full Text] [Related]
9. Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis.
Hussain S; Slevin M; Ahmed N; West D; Choudhary MI; Naz H; Gaffney J
BMC Cell Biol; 2009 Apr; 10():30. PubMed ID: 19389252
[TBL] [Abstract][Full Text] [Related]
10. The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2).
Rusnati M; Borsotti P; Moroni E; Foglieni C; Chiodelli P; Carminati L; Pinessi D; Annis DS; Paiardi G; Bugatti A; Gori A; Longhi R; Belotti D; Mosher DF; Colombo G; Taraboletti G
Angiogenesis; 2019 Feb; 22(1):133-144. PubMed ID: 30168023
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.
Hussain S; Slevin M; Matou S; Ahmed N; Choudhary MI; Ranjit R; West D; Gaffney J
Angiogenesis; 2008; 11(3):245-56. PubMed ID: 18330714
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-2 antagonist and antiangiogenic activity of long-pentraxin 3-derived synthetic peptides.
Leali D; Alessi P; Coltrini D; Rusnati M; Zetta L; Presta M
Curr Pharm Des; 2009; 15(30):3577-89. PubMed ID: 19860702
[TBL] [Abstract][Full Text] [Related]
13. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
[TBL] [Abstract][Full Text] [Related]
14. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
Simantov R; Febbraio M; Silverstein RL
Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
[TBL] [Abstract][Full Text] [Related]
15. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
16. Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors.
Foglieni C; Pagano K; Lessi M; Bugatti A; Moroni E; Pinessi D; Resovi A; Ribatti D; Bertini S; Ragona L; Bellina F; Rusnati M; Colombo G; Taraboletti G
Sci Rep; 2016 Mar; 6():23432. PubMed ID: 27000667
[TBL] [Abstract][Full Text] [Related]
17. Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
Jeanne A; Sick E; Devy J; Floquet N; Belloy N; Theret L; Boulagnon-Rombi C; Diebold MD; Dauchez M; Martiny L; Schneider C; Dedieu S
Oncotarget; 2015 Jul; 6(20):17981-8000. PubMed ID: 26046793
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide.
Leali D; Bianchi R; Bugatti A; Nicoli S; Mitola S; Ragona L; Tomaselli S; Gallo G; Catello S; Rivieccio V; Zetta L; Presta M
J Cell Mol Med; 2010 Aug; 14(8):2109-21. PubMed ID: 19627396
[TBL] [Abstract][Full Text] [Related]
19. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
20. Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis.
Kanda S; Shono T; Tomasini-Johansson B; Klint P; Saito Y
Exp Cell Res; 1999 Nov; 252(2):262-72. PubMed ID: 10527617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
